API Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$0.00
Insider Selling (Last 12 Months): A$0.00

Australian Pharmaceutical Industries Insider Trading History Chart

This chart shows the insider buying and selling history at Australian Pharmaceutical Industries by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Australian Pharmaceutical Industries Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET

This chart shows the closing price history over time for API up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Australian Pharmaceutical Industries Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/29/2022Richard VincentInsiderCancelled2,213,741A$1.55A$3,431,298.55
2/8/2022Richard VincentInsiderIssued731,730A$1.53A$1,115,888.25
See Full Table

SEC Filings (Institutional Ownership Changes) for Australian Pharmaceutical Industries (ASX:API)

Australian Pharmaceutical Industries logo
Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia. It also retails health and beauty products to consumers through a network of Priceline and Priceline Pharmacy franchise stores, and company owned Priceline stores in Australia; sells beauty products through Clear Skincare network of clinics in Australia and New Zealand; and manufactures and distributes pharmaceutical and toiletry goods to New Zealand, Australian, and Asian markets, as well as provides cosmetic products and non-invasive aesthetic beauty services. The company was founded in 1910 and is based in Camberwell, Australia.
Read More on Australian Pharmaceutical Industries

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

453,647 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

2.29%

Beta

N/A